CROSSBOW THERAPEUTICS, INC.

Profile

Company Names

CROSSBOW THERAPEUTICS, INC.

Addresses

1030 MASSACHUSETTS AVE, SUITE 210, CAMBRIDGE, MA 02138

1030 MASSACHUSETTS AVENUE, SUITE 210, CAMBRIDGE, MA 02138

Phone Numbers

860-501-1600

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$67,818,164.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2025-09-17 
$30,250,000.00 
$80,000,000.00 
$49,750,000.00 
Equity 
1
2023-03-29 
$37,568,164.00 
$80,000,000.00 
$42,431,836.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SAKAE 
 
ASANUMA 
DIRECTOR
MITOKYNE, INC.   |  POTENZA THERAPEUTICS, INC.   |  AXIAL BIOTHERAPEUTICS, INC.   |  WEREWOLF THERAPEUTICS, INC.   |  DREN BIO, INC.   |  AXIAL THERAPEUTICS, INC.   |  NORMUNITY HOLDING COMPANY, LLC   |  ORNA THERAPEUTICS HOLDINGS, LLC   |  CROSSBOW THERAPEUTICS, INC.
CHARLES 
 
BAUM 
DIRECTOR
METHYLGENE INC.   |  ODYSSEY THERAPEUTICS, INC.   |  CROSSBOW THERAPEUTICS, INC.   |  TERREMOTO BIOSCIENCES, INC.
ALEXANDRA 
 
CANTLEY 
DIRECTOR
PODIMETRICS, INC.   |  AURON THERAPEUTICS, INC.   |  BEME HEALTH, INC.   |  SUNBIRD BIO, INC.   |  EPIBIOLOGICS, INC.   |  CROSSBOW THERAPEUTICS, INC.   |  TREX HOLDINGS INC.   |  CIRRUS THERAPEUTICS, INC.
TODD 
 
FOLEY 
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.   |  ZALICUS INC.   |  CELLADON CORP   |  SELEXYS PHARMACEUTICALS CORP   |  PROTEON THERAPEUTICS INC   |  ICONIC THERAPEUTICS INC   |  VALERITAS INC   |  TETHEREX PHARMACEUTICALS CORP   |  CLINICAL INK, INC.   |  SEMMA THERAPEUTICS, INC.   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  MOAT BIOTECHNOLOGY CORP   |  CROSSBOW THERAPEUTICS, INC.   |  FIREFLY BIO, INC.   |  AKTIS ONCOLOGY, INC.
ALON 
 
LAZARUS 
DIRECTOR
KEROS THERAPEUTICS, INC.   |  ONCORUS, INC.   |  WEREWOLF THERAPEUTICS, INC.   |  AURON THERAPEUTICS, INC.   |  BLUEJAY THERAPEUTICS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  ENTACT BIO, INC.   |  REUNION NEUROSCIENCE, INC.   |  CROSSBOW THERAPEUTICS, INC.
IRENA 
 
MELNIKOVA 
DIRECTOR
PROTEOSTASIS THERAPEUTICS, INC.   |  UMOJA BIOPHARMA, INC.   |  CROSSBOW THERAPEUTICS, INC.
BRIGGS 
 
MORRISON 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ONCORUS, INC.   |  RIFT BIOTHERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  ARVINAS, INC.   |  WEREWOLF THERAPEUTICS, INC.   |  CARISMA THERAPEUTICS INC.   |  CROSSBOW THERAPEUTICS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  CHARM THERAPEUTICS INC.
ALEXANDER 
 
NOLTE 
EXECUTIVE OFFICER
CROSSBOW THERAPEUTICS, INC.
GERALDINE 
 
PAULUS 
EXECUTIVE OFFICER
CROSSBOW THERAPEUTICS, INC.
DMITRI 
 
WIEDERSCHAIN 
EXECUTIVE OFFICER
CROSSBOW THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-17 
2023-04-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#